Search company, investor...

Stage

Other Investors | Alive

About Informed Medical Communications

Informed Medical Communications specializes in providing communication and documentation solutions within the healthcare sector. Their main offerings include software tools that facilitate clear and efficient documentation and communication between healthcare facilities, patients, and their responsible parties. These tools are designed to educate and inform about patient conditions and assist in managing healthcare provider relationships. It is based in New York, New York.

Headquarters Location

160 Mercer Street

New York, New York, 10012,

United States

Loading...

Loading...

Informed Medical Communications Patents

Informed Medical Communications has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/8/2018

7/7/2020

Optical character recognition, Wireless networking, Mobile phones, Social networking services, Network protocols

Grant

Application Date

10/8/2018

Grant Date

7/7/2020

Title

Related Topics

Optical character recognition, Wireless networking, Mobile phones, Social networking services, Network protocols

Status

Grant

Latest Informed Medical Communications News

Informed Medical Merges with IC Axon

Mar 16, 2011

Informed Medical Merges with IC Axon March 16, 2011 Private equity-backed Informed Medical Communications – a provider of peer-to-peer medical forums, training services and integrated medical communications for the biopharmaceutical industry – has merged with healthcare training company IC Axon. Financial terms of the deal were not released. Montreal-based IC Axon was advised by Fairmount Partners. PRESS RELEASE Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums, training services, and integrated medical communications for the biopharmaceutical industry, and IC Axon, an industry-recognized leader in the design and development of training programs for the healthcare industry, today announced the merger of the two organizations. The combined enterprise will offer a full suite of sales and leadership training, Key Opinion Leader skills development, and medical communications services for the domestic and global biopharmaceutical/medical device industries. This includes medical content development, workshop design and execution, as well as multichannel pull-through programs with highly interactive peer meetings. Steven K. Budd, IMC’s CEO commented, “This merger will create a formidable training company that offers the full continuum of services from multimedia curricula design and content development to elite skills training anchored in our proven model for influencing customers through dialogue. In addition, IMC’s medical communications capabilities will be significantly enhanced by the addition of IC Axon’s team and their expertise in developing customized, engaging medical content.” With growing challenges facing bio-pharmaceutical organizations, IMC and IC Axon executives believe the combined capabilities will provide their healthcare company customers with more comprehensive training and marketing solutions that improve business outcomes and efficiency of spend. Carole Gins, General Manager IC Axon / Dialogue Training and newly appointed President of IMC summarizes, “We are excited by the merger with IMC, as we believe IMC’s unique DialogueTraining(SM) framework for enhancing sales and promotional impact and their team of expert trainers and workshop facilitators provides the perfect complement to IC Axon’s core competency in the design, development, and production of high-impact training programs. We are confident that our respective clients will benefit from the combined training and medical communications capabilities of IC Axon and Informed Medical Communications. ” IMC and IC Axon will continue to operate out of their current locations in Edison, NJ and Montreal, QC, respectively. IC Axon was advised by Fairmount Partners, a specialty investment bank based outside of Philadelphia, and IMC was advised by Excel Partners, based in New York City. About Informed Medical Communications Informed Medical Communications (www.informedmedical.com), headquartered in Edison, NJ, is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The companies include The Peer Group and RxDialogue, industry innovators and leaders in conducting peer-to-peer medical programs and delivering integrated medical communications. Additionally, IMC’s major businesses are enhanced by DialogueTraining, a communications training service for elite skill development for sales organizations and speaker bureaus. The IMC network of companies delivers integrated marketing programs for pharmaceutical marketers, with the goal of improving the dialogue among healthcare practitioners in understanding health conditions and their medical options. IMC is a private-equity backed, privately held company. About IC Axon IC Axon (www.icaxon.com) is a recognized leader in the healthcare training industry, specializing in the design and development of clinically focused training programs for domestic and global pharmaceutical, bio-pharma, and medical device clients. IC Axon offers a wide range of custom education programs and formats tailored to the business and training needs of sales representatives, sales leadership, marketing, and medical teams. Over the past 16 years, IC Axon has reinforced its core competencies in instructional design consulting, medical/clinical content development, medical illustration/graphics creation, technology innovation, and professional project management. Based in Montreal, IC Axon continues to provide innovative and medically valid foundational, launch, and advanced training programs for many of the top pharmaceutical companies in the US and globally. © 2015 Buyouts Insider / Argosy Group LLC

Informed Medical Communications Frequently Asked Questions (FAQ)

  • Where is Informed Medical Communications's headquarters?

    Informed Medical Communications's headquarters is located at 160 Mercer Street, New York.

  • What is Informed Medical Communications's latest funding round?

    Informed Medical Communications's latest funding round is Other Investors.

  • Who are the investors of Informed Medical Communications?

    Investors of Informed Medical Communications include De Novo Ventures.

  • Who are Informed Medical Communications's competitors?

    Competitors of Informed Medical Communications include Oligomerix, CMC Biologics, Irvine Pharmaceutical Services, Trophos, ReSearch Pharmaceutical Services and 7 more.

Loading...

Compare Informed Medical Communications to Competitors

L
Laureate Pharma

Laureate Pharma is a company focused on the healthcare and pharmaceutical industry. It provides a range of services including the synthesis of pharmaceutical substances, the creation of finished dosage forms, and the development and launch of pulmonary drugs. The company primarily sells to the healthcare sector, with a focus on pharmacies and other pharmaceutical companies. It is based in Princeton, New Jersey.

K
Kryosphere

Kryosphere is a full-service biorepository company operating in the biotechnology industry. The company's main services include managing, storing, and transporting biological and pharmaceutical materials, as well as providing cold chain logistics, clinical trial management, and stability storage services. Kryosphere primarily serves sectors such as academia, biopharmaceuticals, bioagriculture, and clinical research. It was founded in 2007 and is based in Durham, North Carolina.

Plexus Ventures Logo
Plexus Ventures

Plexus Ventures is a healthcare advisory boutique operating in the healthcare, pharma, medical devices, biotech, and consumer health sectors. The company offers strategic advisory services, managing long and time-consuming transactions, and provides structure to corporate and business development activities. Primarily, Plexus Ventures caters to healthcare companies of all sizes worldwide. It is based in Santa Monica, California.

A
Adjuvant Research Services

Adjuvant Research Services is a provider of nationwide clinical development temporary staffing for the biopharmaceutical industry. The company's consultants are supplied to the company's biopharmaceutical customers for regional monitoring, in-house monitoring, auditing, medical writing (including manuscript and protocol writing), project management, medical monitoring and pharmacovigilence services).

E
Emiliem

Emiliem operates as a biopharmaceutical company that is engaged in early oncology R&D. The company develops Molecular Targeted Therapeutics (MTTs) for oncology and other indications. MTTs are therapeutic agents that target biologically important processes central to the development and progression of cancer and other diseases. The company's clinical development strategy is focused on identifying patients most likely to respond to treatment and monitoring clinical outcome with specific biomarkers used as diagnostic assays.

Sertanty Logo
Sertanty

Sertanty is a company focused on providing software solutions for drug discovery within the pharmaceutical industry. The company offers a range of products including databases and platforms that support structure-based and ligand-based drug design, as well as services related to cheminformatics and bioinformatics. These tools are designed to assist researchers in identifying and developing new therapeutic compounds. It was founded in 2005 and is based in San Diego, California.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.